Tag Archive for: Conference

Gudrun Vogtentanz, Chief Scientific Officer at AMSilk, to speak at the Rethinking Materials Summit, 14 May 2024

NEURIED, Germany, May 2, 2024 – AMSilk GmbH (“AMSilk”), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that Gudrun Vogtentanz, Chief Scientific Officer, will participate in a panel discussion titled ‘Advancing the Bioeconomy: Plant-Based Specialty Chemicals and Bio-Based Building Block Molecules’ at the Rethinking Materials Summit in London on the 14th of May at 17:15. AMSilk’s […]

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysis aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vessel EINDHOVEN, The Netherlands, 17 April 2024 – Xeltis, […]

JPM ’24: The year’s healthcare barometer gives a more sunny outlook

The JPM Healthcare Conference of 2024 may not have witnessed a mega-merger announcement, but there is anticipation that the M&A market could pick up this year, with predictions that the economic headwinds of recent years could turn into tailwinds.  The recent M&A Firepower report from EY, formerly known as Ernst & Young, has forecast a […]

IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

Non-clinical data demonstrate clear impact of immune modulating vaccines targeting IDO1 and PD-L1 on several tumoral immune escape mechanisms in the tumor microenvironment (TME) leading to enhanced anti-tumor effect NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating cancer vaccines based on its T-win® technology […]